全文获取类型
收费全文 | 66826篇 |
免费 | 5966篇 |
国内免费 | 3621篇 |
专业分类
耳鼻咽喉 | 747篇 |
儿科学 | 877篇 |
妇产科学 | 670篇 |
基础医学 | 8488篇 |
口腔科学 | 1115篇 |
临床医学 | 7491篇 |
内科学 | 11034篇 |
皮肤病学 | 1104篇 |
神经病学 | 4191篇 |
特种医学 | 3198篇 |
外国民族医学 | 19篇 |
外科学 | 7271篇 |
综合类 | 8921篇 |
现状与发展 | 14篇 |
一般理论 | 10篇 |
预防医学 | 4167篇 |
眼科学 | 1684篇 |
药学 | 6748篇 |
51篇 | |
中国医学 | 2987篇 |
肿瘤学 | 5626篇 |
出版年
2024年 | 132篇 |
2023年 | 728篇 |
2022年 | 1848篇 |
2021年 | 3048篇 |
2020年 | 2167篇 |
2019年 | 2082篇 |
2018年 | 2241篇 |
2017年 | 2024篇 |
2016年 | 2226篇 |
2015年 | 3194篇 |
2014年 | 3761篇 |
2013年 | 3853篇 |
2012年 | 5581篇 |
2011年 | 5829篇 |
2010年 | 4071篇 |
2009年 | 3166篇 |
2008年 | 3970篇 |
2007年 | 3873篇 |
2006年 | 3488篇 |
2005年 | 3401篇 |
2004年 | 2555篇 |
2003年 | 2590篇 |
2002年 | 2192篇 |
2001年 | 1543篇 |
2000年 | 1239篇 |
1999年 | 1121篇 |
1998年 | 645篇 |
1997年 | 614篇 |
1996年 | 403篇 |
1995年 | 466篇 |
1994年 | 332篇 |
1993年 | 210篇 |
1992年 | 330篇 |
1991年 | 252篇 |
1990年 | 210篇 |
1989年 | 199篇 |
1988年 | 150篇 |
1987年 | 148篇 |
1986年 | 141篇 |
1985年 | 69篇 |
1984年 | 53篇 |
1983年 | 29篇 |
1982年 | 30篇 |
1981年 | 21篇 |
1980年 | 18篇 |
1979年 | 28篇 |
1977年 | 14篇 |
1974年 | 18篇 |
1973年 | 17篇 |
1969年 | 17篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
121.
P16、Cyclin D1蛋白表达与胰腺癌生物学行为 总被引:2,自引:2,他引:0
目的 探讨P16、CyclinD1蛋白表达水平与胰腺癌发生、发展及预后的关系。方法 应用免疫组织化学SP法结合微波抗原修复法对53例原发性胰腺癌和42例胰腺良性病变及正常组织中P16蛋白及CyclinD1蛋白进行检测。结果 胰腺癌组织、胰腺良性病变和正常组织中P16蛋白的阳性率分别为66.04%和87.71%(P<0.05);CyclinD1表达的阳性率分别为52.83%和23.81%(P<0.05),P16及CyclinD1蛋白表达与胰腺癌的组织分化、病理分期及术后生存期密切相关。结论 P16及CyclinD1蛋白在胰腺癌中的表达可判断胰腺癌的预后。 相似文献
122.
目的比较研究密闭液性环境和干燥环境下供皮区创面的愈合过程. 方法 1996年7月~1997年3月以13例成人断层供皮区创面为研究对象,其中男9例,女4例,年龄20~50岁,创面面积(100~400) cm2,取皮深度中厚,约0.44 mm.同一个创面分为实验组(密闭液性环境)和对照组(干燥环境),采用自身对照法.应用大体、组织学及电镜观察等方法进行观察. 结果密闭液性环境下创面愈合较快,创面组织中成纤维细胞较早活跃、且持续时间较长,再血管化和再上皮化均较早和较快发生. 结论密闭液性环境下创面愈合较快,与组织修复细胞较为活跃、再血管化和再上皮化较快发生有关. 相似文献
123.
传统腺样体切除术后腺样体残留情况调查 总被引:39,自引:0,他引:39
体统的腺样体手术为腺样体刮除术,为非直视下的手术,虽然多数患者手术后症状得得缓解,但临床上也常常看到手术后短时间内症状复发或者缓解不彻底的患儿,这类情况往往和腺样体手术切除不彻底有关。本院自2003年1月-2004年9月间对腺样体切除术后复发再次手术患者,以鼻内镜观察记录腺样体残留情况,对初次手术患者在进行传统腺样体刮除术并止血后,立即进行鼻内镜检查,了解腺样体残留情况并进行鼻内镜下处理,报告如下。 相似文献
124.
Zhong Rui-kun钟瑞琨 Dong Yong-he董永和and Lu Dao-pei陆道培Institute of Hematology Beijing Medical University Beijing 《中华医学杂志(英文版)》1989,102(7):537-544
In order to understand the mechanism of immunosuppression caused by infusion of placental gamma globulin (PGG) in patients with renal allografts, rheumatoid arthritis, and graft – versus –host disease (GCHD) following bone marrow transplantation (BMT) ,we have examined the effect of PGG in vitro and in a model of the xenogeneic , local graft –ver- sus – host reaction (LGVHR) .PGG inhibited lymphocyte proliferation in mixed lymphocyte cultures (MLC) (P<0.005) and depressed interleukin -2 (IL-2) levels in such cultures at 72 hours (P<0.01) . In contrast phytohemagglutinin (PHA) –and pokeweed mitogen (PWM) –induced T and B lymphocyte blastogenesis was not affected by such PGG treatment .PGG treatment .PGG neither decreased the [3H] TdR pulse incorporation in unstimulated lymphocytes nor affected cell viability .Cell cycle analysis by flow cytometry showed that PGG reduced the percentage of cells in S and G2, M phases during the MLC, but did not alter cell cycling during PWM-stimulated proliferation .
An immunosuppressive effect of PGG on the LGCHR was tested in a model of intracutaneous transplantation of PGG –treat human lymphocytes into cyclophosphamide – immunosuppressed rats. Lymphoprep – separated human tonsillar lymphocytes were incubated with RPMI-1640 buffer containing:(1)PGG,4mg/ml,(2) human plasma albumin,4mg/ml,(3)mitomycin-C,25ug/ml, or (4) no additive. Cell of each preparation (3x107cells in 0.1ml) were injected intracutaneously into cyclophosphamide-treated male rats at separate abdominal locations. A fifth site received only the buffer solution. Five days after injection of cells ,each rat received [125 I]IUdR (10uCi) intraperitoneally and was killed after 5 hours. For each site of injection, the diameters of induration were measured and 125 I was counted . There was no difference between buffer – treated and a ibumin – treated groups either in the diameter of the area of induration (t=0.66;P>0.5)or in radioactive counts(t=0.22;P>0.05).In the PGG –treated group, the induration and radioactivity measurements were significantly less than in control groups (t=3.72 and P<0.1;t=2.62 and P<0.02,respectively ) Cytophilic antibodies in PGG were thought to inhibit an early phase of T cell activation, and not to be cytotoxicity .In the LGVHR, the immune response might be abrogated either by immuno- regulatory suppression of T cell function or by toxicity to the infused lymphoid cells. For some clinical purposes, immuno- modulating, human antibodies might be preferred to murine, monoclonal antibodies. 相似文献
125.
100例2型糖尿病患者交感神经皮肤反应研究 总被引:1,自引:0,他引:1
目的探讨交感神经皮肤反应(SSR)检测在评价2型糖尿病(T2DM)自主神经损害中的价值.方法对100例T2DM患者进行SSR检测,30例健康志愿者作为对照.结果2组SSR的起始潜伏期、N波潜伏期、波幅、面积比较差异有显著性意义(P<0.05),P波潜伏期差异无显著性意义(P>0.05).T2DM组72例(72%)患者至少有一肢SSR异常.血糖控制满意组和血糖控制不良组比较,起始和N波潜伏期差异有统计学意义(P<0.05),波幅和面积无显著性意义(P>0.05).T2DM组病程<5年与病程≥5年比较,潜伏期、波幅、面积差异均无统计学意义(P>0.05).结论SSR可作为评价T2DM自主神经损害的客观电生理指标;T2DM患者SSR与血糖控制水平相关,与病程无关. 相似文献
126.
In order to investigate the analgesic effect of needling at “Sitian” points for the nerve root-involved cervical spondylopathy, 68 cases of the nerve root-involved cervical spondylopathy were randomly divided into a treatment group of 46 cases treated by needling at "Sitian" points, and a control group of 22 cases treated by needling at cervical Jiaji points. After 2 therapeutic courses, the therapeutic effects were evaluated by using the visual analogue scale (VAS) and the semeiographic format. The results showed that the markedly effective rate was 78.3% and 54.5%, respectively in the treatment group and the control group, and the difference between the two groups was of significance (P〈0.05). It can be concluded that needling at “Sitian” points can bring about a better therapeutic effect on the improvement of clinical symptoms, ohvsical signs and pain than that of the needling at the cervical Jiaii points. 相似文献
127.
128.
关节镜辅助下的同种异体半月板移植(附4例术后20个月以上随访报告) 总被引:5,自引:0,他引:5
目的:介绍同种异体半月板移植并总结4例关节镜辅助下的同种异体半月板移植的初步临床效果。材料和方法:2005年6月~7月,4例半月板切除术后的患者接受关节镜辅助的同种异体半月板移植手术,其中男性3例、女性1例,平均年龄30.78±7.71岁(21.5~38.5岁)。3例内侧半月板移植,1例外侧半月板移植。随访采用症状询问,体征检查,IKDC、Lysholm和Tegner评分及KT2000测量关节稳定性的方法。4例患者均每半年进行一次X线片及MRI检查,分别观察膝关节的关节间隙改变及移植半月板状态。对所得结果,因病例只有4例,故只进行数据描述,不进行统计学分析。结果:对4例患者均进行了平均21.80±0.81(20~22)个月的随访。所有患者随访时关节活动度均正常,均无明显的膝关节疼痛和肿胀,原来长时间活动后被切除半月板的间室不适完全消失。患者可以胜任日常活动和体育锻炼,无并发症出现。IKDC、Lysholm、Tegner评分均较术前明显提高。KT2000测量发现术后膝关节的稳定性有所改善。X线片检查提示术后患者关节间隙无明显变化。每半年一次的MRI检查提示移植半月板术后1年时替代存活已经很好。结论:关节镜辅助下的同种异体半月板移植安全可行,半月板移植可缓解半月板切除后出现的关节疼痛、肿胀等症状,促进关节功能恢复并使膝关节的稳定性有所改善。 相似文献
129.
Establishment of a human hepatocellular carcinoma cell line highly expressing sodium iodide symporter for radionuclide gene therapy. 总被引:6,自引:0,他引:6
Joo Hyun Kang June-Key Chung Yong Jin Lee Jae Hoon Shin Jae Min Jeong Dong Soo Lee Myung Chul Lee 《Journal of nuclear medicine》2004,45(9):1571-1576
To evaluate the possibility of radionuclide gene therapy and imaging in hepatocellular carcinoma cancer, we investigated the iodine accumulation of a human hepatocellular carcinoma cell line, SK-Hep1, by transfer of human sodium iodide symporter (hNIS) gene. By targeting NIS expression in SK-Hep1, we could also investigate whether these cells concentrate 99mTc-pertechnetate and 188Re-perrhenate as well as 125I in vitro and in vivo. METHODS: The hNIS gene was transfected to human hepatocellular carcinoma SK-Hep1 cell lines using lipofectamine plus reagent. The uptake and efflux of 125I, 99mTc-pertechnetate, and 188Re-perrhenate were measured in the transfected and parental cells. Biodistribution was studied in nude mice bearing SK-Hep1 and SK-Hep1-NIS at 10 and 30 min and at 1, 2, 6, 16, and 23 h after injection of 125I, 99mTc- pertechnetate, or 188Re-perrhenate. In tumor imaging studies, the nude mice were intravenously injected with 188Re-perrhenate and imaged with a gamma-camera equipped with a pinhole collimator at 30 and 60 min after injection. The survival rate (%) was determined by the clonogenic assay after 37 MBq/10 mL (1 mCi/10 mL) 131I and 188Re-perrhenate treatment. RESULTS: SK-Hep1-NIS, stably expressing the NIS gene, accumulated 125I up 150 times higher than that of SK-Hep1. Iodine uptake of SK-Hep1-NIS is completely blocked by perchlorate. NIS gene transfection into SK-Hep1 also resulted in 112- and 87-fold increases of 99mTc-pertechnetate and 188Re-perrhenate uptake, respectively. Iodide efflux from SK-Hep1-NIS was relatively slow, with only 10% released during the initial 5 min, and 60% remained at 25 min. In the biodistribution study using SK-Hep1-NIS-xenographed mice, the tumor uptake of 125I, 188Re-perrhenate, and 99mTc-pertechnetate was 68.0 +/- 15.0, 46.2 +/- 9.1, and 59.6 +/- 16.2 %ID/g (percentage injected dose per gram) at 2 h after injection, respectively. After 188Re-perrhenate injection in SK-Hep1 and SK-Hep1-NIS-xenographed nude mice, whole-body images clearly visualized the SK-Hep1-NIS tumor, whereas the control tumor was not visualized. The survival rate (%) of SK-Hep1-NIS was markedly reduced to 46.3% +/- 10.1% and 28.9% +/- 5.2% after 37 MBq/mL (1 mCi/10 mL) 131I and 188Re-perrhenate treatment compared with the survival rates of the parental cells. These results demonstrated that SK-Hep1-NIS could be selectively killed by the induced 131I and 188Re-perrhenate accumulation through NIS gene expression. CONCLUSION: NIS-based gene therapy using beta-emitting radionuclides has the potential to be used in hepatocellular carcinoma management. 相似文献
130.